Sentences with phrase «about cancer biology»
An initial consultation includes client education about cancer biology, cancer staging, patient prognosis and available treatments.
https://flvrc.com/
Currently, Vogelstein is focusing on new, minimally invasive techniques for the early diagnosis of cancer based on his previous findings, and therapeutic approaches that apply what researchers now know about cancer biology.
Not exact matches
«Everything we talked about was about research directly on the embryo,» for example, to improve on infertility treatment or better understand cancer biology, says R. Alta Charo, a law professor and bioethicist at the University of Wisconsin Law School who was a member of the NIH Human Embryo Research Panel in the mid-1990s, which considered how embryos might be used in research.
«There are a lot of disparate theories about what could have a profound impact on aging and age - related processes, but at this point, we simply do not have evidence - based strategies to significantly change our life expectancy that come in the form of a pill,» says Ronald DePinho, professor of cancer biology and president of the University of Texas MD Anderson Cancer Ccancer biology and president of the University of Texas MD Anderson Cancer CCancer Center.
Ask a cross-section of scientists how they got into cancer research, and you'll hear about a dizzying variety of routes from fields as diverse as biology, pharmacology, mathematics, and medicine.
Cynthia Kuhn, professor of pharmacology and cancer biology at Duke University in Durham, North Carolina, is one of about 15 associate editors at the Journal of Pharmacology and Experimental Therapeutics (JPET).
Their research was never driven by curiosity about biology, Vogelstein says, but by «an overwhelming desire to empty the cancer clinics across the street.»
When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer Ccancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer CCancer Center.
A novel Yale study answers age - old questions about how cancers spread by applying tools from evolutionary biology.
«We're excited about the application of CombiGEM to probe complex multifactorial phenotypes, such as stem cell differentiation, cancer biology, and synthetic circuits,» Lu says.
«Forty years ago, very little was known about breast cancer disease biology — such as subtypes, differences in radio - sensitivities, radio - resistances, local recurrence and in metastatic potential,» explains Bedrosian, the study's senior author.
«Scientists have learned a lot about development, gene regulation, and cancer biology, among other things, by studying C. elegans.
Alessandra Salgueiro, a graduate student in cancer biology, asked Price about the most effective ways to contact members of Congress on policy issues.
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 andCancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 andcancer biology published between 2010 and 2012.
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by replicating selected results from a substantial number of high - profile papers in the field of cancer biology published between 2010 andCancer Biology seeks to address growing concerns about reproducibility in scientific research by replicating selected results from a substantial number of high - profile papers in the field of cancer biology published between 2010 andcancer biology published between 2010 and 2012.
ABOUT COLD SPRING HARBOR LABORATORY Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology.
About the National Cancer Institute The National Cancer Institute leads the National Cancer Program and the NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researCancer Institute The National Cancer Institute leads the National Cancer Program and the NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researCancer Institute leads the National Cancer Program and the NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researCancer Program and the NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researcancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researcancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researcancer biology, the development of new interventions, and the training and mentoring of new researchers.
As part of our coverage of the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 — 6 in Chicago, we are speaking with Gordon Mills, MD, PhD, chair of the department of systems biology and professor of medicine and immunology at the University of Texas MD Anderson Cancer Center in Houston, about ways to incorporate homologous recombination markers into clinical practice for ovarian cCancer Center in Houston, about ways to incorporate homologous recombination markers into clinical practice for ovarian cancercancer.
In addition to developing the new genetically engineered mouse model for the form of cancer called glioblastoma multiforme, the researchers made a key discovery about brain tumor biology via the mice.
Jennifer R. Grandis, a professor of otolaryngology and pharmacology and chemical biology at the University of Pittsburgh School of Medicine and a senior author of one of the Science papers, bemoaned the dearth of genetic information about head and neck cancer several years ago at a conference where Garraway had given a talk about the genomic landscape of melanoma.
«Mouse models of human cancer have taught us a great deal about the basic principles of cancer biology,» says Inder Verma, Ph.D., a professor in the Laboratory of Genetics.
«When we think about radiation therapy, it is high technology, but the complexity of cancer requires that we have a better understanding of the biology,» says Marikki Laiho, the Willard and Lillian Hackerman Professor of Radiation Oncology and Vice Chair of Research for the Department of Radiation Oncology and Molecular Radiation Sciences.
The findings could help improve the assessment of individuals» risk and point researchers to clues about the underlying biology of this disease, which is the second leading cancer killer in the U.S.
If one could identify these molecules, they would yield information about both the basic biology of metastatic cancer and possible therapeutic targets, and that is exactly what Quigley is trying to do.
We utilize an integrative platform that coordinates these approaches to answer specific questions about lung cancer biology and define strategies for diagnosis and therapeutic intervention.
In my Stopping Cancer Before it Starts DVD, I go into detail about the quantum biology of oxidative phosphorylation.
Munich, Germany About Blog Definiens mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer - relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies.
Munich, Germany About Blog Definiens mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer - relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies.
Munich, Germany About Blog Definiens mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer - relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies.
Munich, Germany About Blog Definiens mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer - relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies.
Munich, Germany About Blog Definiens mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer - relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies.